Cancer Currents: An NCI Cancer Research Blog
A blog featuring news and research updates from the National Cancer Institute.
-
NCI and NIH announce efforts to establish international collaborations that can accelerate progress in reducing the global cancer burden.
-
NCI’s new application programming interface (API) that allows anyone to build online tools that help people find NCI-supported clinical trials.
-
The Impact and Future of the Childhood Cancer Survivor Study: An Interview with Greg Armstrong, M.D.Dr. Greg Armstrong of the Childhood Cancer Survivor Study discusses this long-running study and its future.
-
Pancreatic cancer cells instruct healthy cells around them to provide nutrients they need to survive and grow, a new study suggests.
-
NCI Acting Director Dr. Douglas R. Lowy, M.D., thanks the cancer community for contributing to the Cancer Moonshot Blue Ribbon Panel report, which was presented to the National Cancer Advisory Board on September 7.
-
In a recent study, researchers showed that a new approach may provide a safer way to perform stem cell transplants for treating cancer and other diseases.
-
Stem cells engineered to mimic medulloblastoma development may help researchers identify potential new treatments, according to a new study.
-
A study suggests that doctors could use circulating tumor DNA to quickly identify patients who are responding to T-cell transfer immunotherapy.
-
FDA granted pembrolizumab an accelerated approval for patients with recurrent or metastatic head and neck cancer that has continued to progress despite standard treatment with chemotherapy.
-
A nanoparticle that mimics Salmonella may help to counteract chemotherapy resistance, according to a new study.